ARCA biopharma, Inc. (ABIO)
NASDAQ: ABIO · IEX Real-Time Price · USD
3.285
-0.025 (-0.76%)
At close: Jul 19, 2024, 4:00 PM
3.320
+0.035 (1.07%)
Pre-market: Jul 22, 2024, 7:06 AM EDT
ARCA biopharma Market Cap
ARCA biopharma has a market cap or net worth of $47.66 million as of July 22, 2024. Its market cap has increased by 61.55% in one year.
Market Cap
47.66M
Enterprise Value
11.75M
1-Year Change
61.55%
Ranking
Category
Stock Price
$3.29
Market Cap Chart
Since December 1, 1998, ARCA biopharma's market cap has decreased from $63.10M to $47.66M, a decrease of -24.48%. That is a compound annual growth rate of -1.09%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 19, 2024 | 47.70M | 94.69% |
Dec 29, 2023 | 24.50M | -28.36% |
Dec 30, 2022 | 34.20M | 10.32% |
Dec 31, 2021 | 31.00M | -17.11% |
Dec 31, 2020 | 37.40M | 310.99% |
Dec 31, 2019 | 9.10M | 97.83% |
Dec 31, 2018 | 4.60M | -71.07% |
Dec 29, 2017 | 15.90M | -38.61% |
Dec 30, 2016 | 25.90M | -38.48% |
Dec 31, 2015 | 42.10M | 108.42% |
Dec 31, 2014 | 20.20M | -23.19% |
Dec 31, 2013 | 26.30M | 345.76% |
Dec 31, 2012 | 5.90M | -43.81% |
Dec 30, 2011 | 10.50M | -62.50% |
Dec 31, 2010 | 28.00M | 12.90% |
Dec 31, 2009 | 24.80M | 49.40% |
Dec 31, 2008 | 16.60M | -83.01% |
Dec 31, 2007 | 97.70M | -53.89% |
Dec 29, 2006 | 211.90M | -38.22% |
Dec 30, 2005 | 343.00M | 8.07% |
Dec 31, 2004 | 317.40M | 19.05% |
Dec 31, 2003 | 266.60M | 1,233.00% |
Dec 31, 2002 | 20.00M | -86.45% |
Dec 31, 2001 | 147.60M | -25.11% |
Dec 29, 2000 | 197.10M | -10.98% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Modular Medical | 49.78M |
Marker Therapeutics | 49.14M |
Reneo Pharmaceuticals | 49.13M |
Estrella Immunopharma | 48.38M |
Lantern Pharma | 48.20M |
Elicio Therapeutics | 47.82M |
Carisma Therapeutics | 47.36M |
NextCure | 47.00M |